TY  - EJOU
AU  - LI, WENJUAN 
AU  - SONG, GE 

TI  - Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving
T2  - BIOCELL

PY  - 2020
VL  - 44
IS  - 2
SN  - 1667-5746

AB  - From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in
clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause
pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential
treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this
review for a brief summary.
KW  - SARS-CoV2
KW  -  Cellular mechanism
KW  -  Therapies
KW  -  Antibody
KW  -  Vaccine

DO  - 10.32604/biocell.2020.010018